As the first CAR-T treatment for…
As the first CAR-T treatment for an autoimmune disease draws [...]
As the first CAR-T treatment for an autoimmune disease draws [...]
Pfizer has pumped the brakes on six early-stage assets, including [...]
Exxel Pharma is eyeing a listing on the NYSE American [...]
Wave Life Sciences has the fate of its lead RNA [...]
Daiichi Sankyo’s development of ADCs continues to hit turbulence. The [...]
Having already secured regional rights to vTv Therapeutics’ inflammation drug, [...]
The FDA warned Corcept Therapeutics that it would face significant [...]
Moderna Chief Medical Officer Jacqueline Miller, M.D., is stepping down [...]
Chugai Pharmaceutical has dropped its only clinical candidate that was [...]
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking [...]